Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer.

Hazard ratios (HR) for deep myometrial invasion and lymphovascular space invasion were fairly similarly increased for the two subgroups, although the HR for deep myometrial invasion in the NSMP subgroup did not reach statistical significance (HR 2.9, 95% confidence interval [CI] 0.83–9.9; p = 0.097).

also in 111,027 other papers